# Amyris

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/amyris

- Industry: Biotechnology
- Headquarters: Emeryville, US
- Website: www.amyris.com
- Total disclosed funding: $144M
- Latest round: Series C (Jul 31, 2009)
- Investors on record: 5

## About

Founded in 2003 in Emeryville, US, Amyris, Inc. focuses on sustainable ingredient production. The company has undergone strategic pivots, including a recent RESTRUCTURING funding round where they raised USD 190.00 mn from investors including Foris Ventures. The total amount raised by the company to date is USD 190.00 mn. The founding team includes Abenet Adugna, Alex Bennett, Fleur Insley, Helen Khor, Julia Brow, Nastassia Johnson, and Vincent Martin, with Kathy L. Fortmann currently serving as CEO.

Amyris produces sustainable ingredients using synthetic biology, primarily through sugarcane fermentation. Their product range includes bioidentical molecules for personal care, food and beverage sweeteners, pharmaceuticals, and fine fragrances. Amyris caters to various industries, emphasizing environmentally-friendly solutions, with significant operations in North America, Europe, and parts of Asia.

## Funding rounds

- Series C, Jul 31, 2009, $25M — Kleiner Perkins, DAG Ventures, Khosla Ventures, TPG Biotech, Votorantim Group
- Series B, Sep 22, 2008, $27M — Kleiner Perkins, DAG Ventures, Khosla Ventures, TPG Biotech
- Series B, Jun 13, 2008, $34M — Kleiner Perkins, DAG Ventures, Khosla Ventures, TPG Biotech
- Series B, Sep 18, 2007, $38M — Kleiner Perkins, DAG Ventures, Khosla Ventures, TPG Biotech
- Series A, May 25, 2007, $14M — Kleiner Perkins, Khosla Ventures, TPG Biotech
- Series A, May 25, 2006, $6.5M — Kleiner Perkins, Khosla Ventures, TPG Biotech

## Investors

- Kleiner Perkins (https://capitalatlas.ai/funds/kleiner-perkins) — Series A, Series B, Series C
- Khosla Ventures (https://capitalatlas.ai/funds/khosla-ventures) — Series A, Series B, Series C
- TPG Biotech (https://capitalatlas.ai/funds/tpg-biotech) — Series A, Series B, Series C
- DAG Ventures (https://capitalatlas.ai/funds/dag-ventures) — Series B, Series C
- Votorantim Group — Series C